Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19319
Title: Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Agents/pharmacology,Antineoplastic Agents, Phytogenic/pharmacology,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Cisplatin/pharmacology,Disease Progression,Disease-Free Survival,Drug Resistance, Neoplasm,Female,Granulocyte Colony-Stimulating Factor/administration & dosage,Humans,Leukopenia/chemically induced,Middle Aged,Neoplasm Recurrence, Local/*drug therapy/pathology,Neutropenia/chemically induced,Ovarian Neoplasms/*drug therapy/pathology,Paclitaxel/administration & dosage/*analogs & derivatives/pharmacology,Prospective Studies,*Taxoids,Treatment Outcome,Vinblastine/administration & dosage/*analogs & derivatives
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19319
ISSN: 0923-7534
Link: http://www.ncbi.nlm.nih.gov/pubmed/12853352
http://annonc.oxfordjournals.org/content/14/7/1094.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Aravantinos-2003-Phase II study of do.pdf79.99 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons